Elevated expression of N‐myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis

Author:

Sugita Yasuo1ORCID,Furuta Takuya2ORCID,Takahashi Kenji3,Higaki Koichi4,Murakami Yuichi5,Kuwano Michihiko5,Ono Mayumi5,Abe Hideyuki6,Akiba Jun6,Morioka Motohiro7

Affiliation:

1. Department of Neuropathology Neurology Center, St. Mary's Hospital Kurume Japan

2. Department of Pathology Kurume University School of Medicine Kurume Japan

3. Department of Neurosurgery Neurology Center, St. Mary's Hospital Kurume Japan

4. Department of Pathology St. Mary‘s Hospital Kurume Japan

5. Basic Medical Research Unit St. Mary‘s Research Center Kurume Japan

6. Department of Surgical Pathology Kurume University School of Medicine Kurume Japan

7. Department of Neurosurgery Kurume University School of Medicine Kurume Japan

Abstract

N‐myc downstream regulated gene 1 (NDRG1) is a member of the NDRG family, of which four members (NDRG1, NDRG2, NDRG3, and NDRG4) have been identified. NDRG1 is repressed by c‐MYC and N‐MYC proto‐oncogenes. NDRG1 is translated into a 43 kDa protein that is associated with the regulation of cellular stress responses, proliferation, and differentiation. In this study, we aimed to clarify the relationship between progression of glioblastoma (GB) IDH‐wildtype and NDRG1 expression in tumor cells. We assessed the expression of NDRG1 in 41 GBs using immunostaining and evaluated its prognostic significance. NDRG1 expression by GBs was evaluated using Histoscore, which showed high and low scores in 23 and 18 cases, respectively. NDRG1‐positive cells were strongly expressed in Ki‐67 labeled proliferating tumor cells and CD105 positive proliferating microvessels around the area of palisading necrosis. Statistical analyses showed lower survival rates in the high‐score group than the low‐score group (P < 0.01). This study indicated that overexpression of NDRG1 by GB reflects tumor angiogenesis and poor patient prognosis.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3